Larsson-Sciard, E. L., Dethlefs, S., & Brahic, M. (1997). In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence.
Chicago Style CitationLarsson-Sciard, E L., S. Dethlefs, i M. Brahic. In Vivo Administration of Interleukin-2 Protects Susceptible Mice From Theiler's Virus Persistence. 1997.
Cita MLALarsson-Sciard, E L., S. Dethlefs, i M. Brahic. In Vivo Administration of Interleukin-2 Protects Susceptible Mice From Theiler's Virus Persistence. 1997.
Atenció: Aquestes cites poden no estar 100% correctes.